Get documents about "Notices Obituary
Document Sample
Notice 411
to collect such information in a single 1980. After a short description of the mechanism of attachment of treponemes to
volume. Drs Schell and Musher edit this clinical aspects of syphilis and yaws which cell surfaces is discussed.
monograph to which 24 leading authorities should prove more useful to laboratory Overall the book is well edited and
have contributed. The result is a well workers than to physicians, there is a good provides a relatively up to date account of
balanced review of recent advances in the account of experimental infection of progress in treponemal infection. The
treponematoses, particularly syphilis. In rabbits and hamsters with Treponema monograph should appeal to anyone inter-
the first part of the volume there is a resume pallidum. ested in the immunology and pathogenesis
of the morphological, biochemical, and The third, and largest, section of the of syphilis. It is expensive, however, and is
genetic aspects of the virulent treponemes. monograph is devoted to the immunology more likely to be purchased by libraries
Inevitably, the papers cited in most of syphilis. Cell mediated and humoral than by individuals.
chapters were not published later than immune responses are detailed, and the
Notices
Symposium on skin and the nervous system Journal of African Union Against Venereal Infections of the Genital Tract
Diseases
The third symposium on skin and the The Royal College of Pathologists is
nervous system, entitled "New methods A new journal of STD in Africa is being arranging a half day (2.00 to 6.00 pm)
and advances in the study of skin launched and the first issue will appear in symposium on infections of the genital tract
innervation," is to be held from 24 to 29 December 1983. It will include all aspects of on Tuesday 17 April 1984 in London. The
March 1984 in Vienna, Austria. For further STD particularly of special interest and symposium is open to members of the
information, please contact: Professor W relevance to Africa. The journal will college, trainee pathologists, and workers
Gebhart, Department of Dermatology II, initially be published quarterly. in disciplines associated with the subject.
University of Vienna, Vienna Medical Articles for forthcoming issues are For further information please contact:
Academy for Postgraduate Education, required in duplicate. Annual subscriptions Christine Peddle, Scientific Meetings
Alser Strasse 4, A-1090 Vienna, Austria will be $25 in Africa and $30 from other Secretary, The Royal College of
(tel: (0222) 42 13 83). continents. Cheques and other forms of Pathologists, 2 Carlton House Terrace,
payments should be made to AUVDT. The London SWIY 5AF (tel: 01-930 5861).
first issue will be sent free to all interested.
For further information, article
subscription, and payments, please write
to: Professor Herbert Nsanze, Editor,
African Journal of Sexually Transmitted
Diseases, PO Box 30588, Nairobi, Kenya.
Obituary
PROFESSOR V S RAJAN, MD,
FRCP(ED)
News of the sudden death of professor Treponematoses, he worked to increase home and when his colleagues elected him
Rajan, dermatovenereologist at Middle government awareness and improve the to a personal chair their action was
Road Hospital, Singapore will sadden his practices of his colleagues. applauded. Few men grew into their job as
many friends throughout the world. Most His international reputation rested not rapidly as did Professor Rajan, and he wore
especially he will be a loss to those in the only on his example, teaching, and his academic mantle with rare assurance.
western Pacific region and south east Asia organisational abilities, but on his research Many of us will long remember him, not
where, under the auspices of the World into both dermatology and venereology, only for his well used talents, but also for
Health Organisation and the International particularly gonorrhoea. his grace and quiet, unfailing courtesy.RSM.
Union against the Venereal Diseases and His qualities did not go unnoticed at
BrJ VenerDis 1983;59:412-9
Index to Volume 59, 1983
Authors and subjects are indexed together. There is a separate index of articles abstracted and another of authors of
articles abstracted
Abortion, therapeutic, pelvic inflammatory disease after, BERG S W. See ZAJDOWICZ T R et al, 176
associated with C trachomatis, 189 BHARGAVA R K and THIN R N T: Subpreputial carriage of
Acrosoxacin in treatment of uncomplicated gonorrhoea, aerobic microorganisms and balanitis, 131
242 BIDDLE J. See ODUGBEMI T o et al, 41, 285
Actinomyces in the female genital tract, 317 BILGERI Y R. See DUNCAN M o et al, 265
Acyclovir, topical, in the treatment of initial herpes, 116 Biological false reactions (BFP) and the continuing value
ADEYEMI-DORO F A B. See ASHIRU J o et al, 325 of the VDRL test, 340
Africa, plasmid profile, serogrouping and auxotyping of BITTINER J B. See WALSH R i et al, 242
N gonorrhoeae isolates from Africa, 41 BLACKWELL C C. See KINANE D F et al, 44
ALBRITTON W L. See ODUGBEMI T o et al, 41, 285 Blood group, secretor status and susceptibility to
ALDERETE J F. See MORRISON-PLUMMER et al, 75 infection by N gonorrhoeae, 44
Amenorrhoea, secondary, associated with chlamydial BOOK REVIEW
infection, 105 BANCROFT J: Human sexuality and its problems (1983),
Amine content of vaginal fluid from patients with T 344
vaginalis and gardnerella associated non-specific CENTERS FOR DISEASE CONTROL: Quality assurance
vaginitis, 302 guidelines for STD clinics (1982), 409
Anaerobes in genitourinary infections in men, 255 HOLMES K K and MXRDH P-A, eds: International
Anaerobes, isolation and identification from male and perspectives on neglected sexually transmitted
female urogenital tracts, 182 diseases-impact on venereology, infertility, and
ARAMESH B. See DAROUGAR s et al, 53 maternal and infant health (1983), 410
ARIYARIT C. See PANIKABUTRA K et al, 298 LLOYD-DAVIES R W, GOW J G, DAVIES D R: A colour at-las of
ARKO R J, WONG K-H, SMITH S J, FINLEY-PRICE K G: urology (1983), 344
Antigonococcal effects of vaginal tampons, 94 MLRDH P-A, HOLMES K K, ORIEL J D, PIOT P, SCHACHTER J,
ARNOLD K. See NG W S etal, 232 eds: Chlamydial Infections (1982), 211
Arsenic, chemotherapy and cure of syphilis by: Paul McCORMACK W M, ed: Diagnosis and treatment of
Ehrlich, 404 sexually transmitted diseases (1983), 410
ASHIRU J 0, OGUNBANJO B 0, ROTOWA N A, MASKELL R; Urinary Tract Infections: Current Topics in
ADEYEMI-DORO F A B, OSOBA A 0: Intraoral condylomata Infection No 3 (1982), 139
acuminata: a case report, 325 SCHELL R D and MUSHER D M, eds: Pathogenesis and
Asia, south east, penicillinase-producing N gonorrhoeae immunology of treponemal infection, 411
in, 232 WILLCOX R R and WILLCOX J P,: Venereological Medicine
ATIA W A, EMMERSON A M, HOLMES D: Sultamicillin in the (1982), 139
treatment of gonorrhoea caused by penicillin sensitive BRADFORD D L and PHILPOT C R: A survey of sexually
and penicillinase producing strains of Neisseria transmitted disease centres in Australia, 330
gonorrhoeae, 293 BROWN S T. See ODUGBEMI T o et al, 41
ATTILI V R, HIRA S K, DUBE M K: Schistosomal genital BUCHAN A. See WOODMAN C B J et al 311
granulomas: a report of 10 cases, 269 Buschke-Loewenstein tumour of the penis, 273
Australia, survey of STD centres in, 330
CALUBIRAN O V. See TUPASI T E et al, 172
BAIN S S R. See YOUNG H, 228 Candidosis, vaginal, econazole and clotrimazole in, 56
Balanitis, subpreputial carriage of aerobic micro- CATTERALL R D: Sexually transmitted diseases in the
organisms, 131 Republic of Ireland, 66
BALLARD R C. See DUNCAN M o et al, 265 CATTERALL R D: STD-seventh national conference of the
BALSDON M J. See SANDERSON B E et al, 302 Indian Association, 335
BARLOW D. See THIN R N et al, 364 CATTERALL R D: STD-third African regional conference,
BARR J. See MAW R D et al, 407 337
BASEMAN J B. See MORRISON-PLUMMER et al, 75 CATTERALL R D. See FULFORD K W M et al, 376, 381, 386
BELARDI M. See FANTASIA M et al, 342 Cefaclor as alternative to spectinomycin treatment in
BELLO C S S, ELEGBA 0 Y, DADA J D: Sexually transmitted uncomplicated gonorrhoea, 298
diseases in northern Nigeria: five years' experience in a Cefamandole as alternative to spectinomycin treatment in
university teaching hospital clinic, 202 uncomplicated gonorrhoea, 298
BELSEY E M: Diagnosis of gonorrhoea in women: a Cefotaxime, single 1 g dose in the treatment of
national survey, 59 penicillinase-producing N gonorrhoeae, 100
412
Index 413
Cefoxitin and ceftriaxone compared in the treatment of MAW R D and HANLEY 0: Cervical cytology figures for
penicillin-resistant gonococcal urethritis, 176 1970-81, 408
Cefoxitin v procaine penicillin in treatment of MAW R D, HORNER T, BARR J: Comparison of procaine
gonorrhoea, 406 penicillin, mezlocillin, and doxycycline in treatment of
Ceftriaxone and cefoxitin compared in the treatment of uncomplicated gonorrhoea, 407
penicillin-resistant gonococcal urethritis, 176 MORRIS C A: Continuing value of VDRL test and
Cefuroxime in uncomplicated infections due to biological false reactions, 340
penicillinase-producing strains of N gonorrhoeae, 172 SINGH K G, SINGH G, PANDEY S S, KAUR P: Penicillinase
Cervical cytology, figures for 1970-81, 408 producing Neisseria gonorrhoeae in eastern India, 278
Cervix, epithelial abnormalities on colposcopy in patients SORVILLO F, MORI K, SEWAKE W, FISHMAN L: Sexual
with vulval warts, 327 transmission of Strongyloides stercoralis among
Cervix uteri, abnormalities of, in women with vulval homosexual men, 324
warts, 120 TALBOT M D, SPENCER R C, KINGHORN G R: Vancomycin
Chancriform papule: a case report, 402 sensitive penicillinase producing Neisseria
Chancroid, comparison of sulphamethoxazole and co- gonorrhoeae, 277
trimoxazole treatments, 320 TARDIEU J C and FRIEDEL J: Incidence of herpes simplex
Chancroid, treatment with erythromycin, 265 virus types 1 and 2 in herpes genitalis in Strasbourg
CHAU P Y. See NG W s et al, 232 France, 138
CHIEF MEDICAL OFFICER: Sexually transmitted diseases VEERAVAHAU M, SUMATHIPALA A H T, CLAY J C: Cefoxitin v
(extract from the annual report for 1980), 134 procaine penicillin in the treatment of uncomplicated
CHIEF MEDICAL OFFICER Sexually transmitted diseases gonorrhoea, 406
(extract from the annual report for 1981), 206 YOUNG H, ROBERTSON D H H, HUNTER J M: Role of the
CHISWELL C P. See COPLEY C G et al, 237 VDRL test in detection of syphilis, 340
CHITWARAKORN A. See PANIKABUTRA K et al, 298 Co-trimazole compared with sulphamethoxazole in
Chlamydiae, antibody serotypes against, 341 treatment of chancroid, 320
Chlamydial genital infection in Iranian prostitutes, 53 CRESCIMBENI E. See FANTASIA M et al, 342
Chlamydial infection, prevalence in promiscuous women, CRISOLOGO L B. See TUPASI T E et al, 172
103 Cryoglobulinaemia, essential mixed, and false-positive
Chlamydia trachomatis, inactivation by normal human serological tests for syphilis, 33
serum, 369
C trachomatis, isolation from prostatic fluid in association
with inflammatory joint or eye disease, 375 DADA J D. See BELLO C S S et al, 202
C trachomatis, pelvic inflammatory disease after DAROUGAR S, ARAMESH B, GIBSON J A, TREHARNE J D, JONES B R:
therapeutic abortion, 189 Chlamydial genital infection in prostitutes in Iran, 53
C trachomatis, postgonococcal conjunctivitis caused by, DAROUGAR S. See HUNTER J M et al, 341
109 DAVIDSON PARKER J. See THIN R N T et al, 116
C trachomatis, secondary amenorrhoea associated with, 105 D'COSTA L J. See FAST M v et al, 320
Chloramphenicol, treatment for neurosyphilis, 225 D'COSTA L J. See MIRZA N B et al, 186
CLARKE S K R. See LACEY C J N et al, 277 DE JESUS I. See TUPASI T E et al, 172
DE KONING G A J, TIO D, VAN DEN HOEK J A R, VAN KLINGEREN B:
CLAY J C. See VEERAVAHAU M et at, 406
CLAY J C. See WOODMAN C B J et al, 311 Single 1 g dose of cefotaxime in the treatment of
Clotrimazole and econazole in vaginal candidosis, 56 infections due to penicillinase-producing strains of
COLLEY N V. See WALKER P G et al, 120
Neisseria gonorrhoeae, 100
COPLEY C G, CHISWELL C P, EGGLESTONE S i: Neisseria gonorr- DE ROO A. See ORANJE A P et al, 47
hoeae: stability of typing markers after natural DE WITT W. See ODUGBEMI T o et al, 41, 285
transmission, 237 DIGGORY P: Role of the Venereal Disease Research
CORRESPONDENCE
Laboratory test in the detection of syphilis, 8, 341
FANTASIA M, FILETICI E, MONDELLO F, CRESCIMBENI E, Donovanosis, primary endometrial and endocervical, 198
BELARDI M: P-lactamase producing Neisseria Doxycycline compared with procaine penicillin and
gonorrhoeae in Rome, Italy, 342 mezlocillin in gonorrhoea, 407
FUNG H W and NG W W S Penicillinase- DUBE M K. SeeATTILI V Ret al, 269
producing Neisseria gonorrhoeae in 21 patients DUBISKI S. See WICHER K et al, 349
attending an STD clinic in Hong Kong, 138 DUERDEN B I. See MASFARI A N et al, 255
HUNTER J M, FORSEY T, DAROUGAR S, SMITH I W, PEUTHERER DUNCAN M 0, BILGERI Y R, FEHLER H G, BALLARD R C:
J F, MacAULAY A: Serotypes of antibodies Treatment of chancroid with erythromycin: a clinical and
against chlamydiae, 341 microbiological appraisal, 265
KINGHORN G R and JONES B M: Non-specific vaginitis, 278 DYSON J L. See WALKER P G et al, 327
LACEY C J N, MEADEN J D, CLARKE S K R: Hepatitis B virus
infections in homosexual men, 277 EASMON C S F. See HERZOG C et al, 289
LOO P S, FELMINGHAM D, RIDGWAY G L, ORIEL J D: Treatment ECHEVERRIA P. See NG w s et al, 232
of gonococcal infections in men with single dose Econazole and clotrimazole in vaginal candidosis, 56
thiamphenicol, 407 EGGLESTONE S I. See COPLEY C G etat, 237
414 British Journal of Venereal Diseases
Ehrlich Paul: Pioneer of chemotherapy and cure by GOH B T, MORGAN-CAPNER P, LIM K S: Isolation of Chiamydia
arsenic, 404 trachomatis from prostatic fluid in association with
Eire, STD in, 66 inflammatory joint or eye disease, 373
ELEGBA Y. See BELLO C S S et al, 202
0 GOLDMEIER D, LYNCH D, MELLARS B J: Immunocompromise
ELISA for detecting gonococcal antibodies using two syndrome in homosexual men: prevalence of possible risk
antigenically different gonococcal pili, 89 factors and screening for the prodrome using an accurate
ELISA for detection of serum antibody to outer membrane white cell count, 127
proteins of Tpallidum, 75 GOLDMEIER D. See SARGEAUNT P G et al, 193
ELISA, value of testing women with asymptomatic Gonococcal antibodies, ELISA for, using two antigenically
gonorrhoea for antibodies to gonococcal pili, 85 different gonococcal pili, 89
EMMERSON A M. See ATIA W A et al, 293 Gonococcal serology, a comparison of three different tests,
Entamoeba histolytica in male homosexuals, 193 47
Erythromycin, treatment of chancroid, 265 Gonococcal urethritis, penicillin-resistant, cefoxitin and
EYKYN S. See THIN R N et al, 364 ceftriaxone compared in treatment of, 176
Gonorrhoea, acrosoxacin in treatment of, 242
Gonorrhoea, antigonococcal effects of vaginal tampons, 94
FAINE S. See WONG G H W et al, 21 Gonorrhoea, asymptomatic, diagnostic value of ELISA for
FANTASIA M, FILETICI E, MONDELLO F, CRESCIMBENI E, antibodies to gonococcal pili in women, 85
BELARDI M: P-lactamase producing Neisseria gonorrhoeae Gonorrhoea, cefoxitin v procaine penicillin in, 406
in Rome, Italy (correspondence), 342 Gonorrhoea in women, diagnosis, 59
FAST M V, NSANZE H, PLUMMER F A, D'COSTA L J, MacLEAN I W, Gonorrhoea, procaine penicillin, mezlocillin, and
RONALD A R: Treatment of chancroid: a comparison of doxycycline treatments compared, 407
sulphamethoxazole and trimethoprim-sulpha- Gonorrhoea, single dose thiamphenicol in, 407
methoxazole, 320 Gonorrhoea, sultamicillin in treatment of, 293
FEHLER H G. See DUNCAN M et al, 265
o
Gonorrhoea, uncomplicated in men, cefaclor and
FELMINGHAM D. See LOO P S et al, 407 cefamandole as alternatives to spectinomycin treatment,
FELTON W F. See SCHOBER P C et al, 217 298
FIDDIAN A P. See THIN R N et al, 116 Granuloma inguinale. See donovanosis, 198
FILETICI E. See FANTASIA M et al, 342 GRAVES S. See WONG G H w et al, 21, 220
Fingers, primary syphilis of, 169 GRICE G C, HAFIZ S: Actinomyces in the female genital tract:
FINLEY-PRICE K G. See ARKO R J et al, 94 a preliminary report, 317
FISHMAN L. See SORVILLO F et al, 342 GRUBB C. See WALKER P G et al, 120
FITZGERALD T J. See QUIST E E et al, 11
FORSEY T. See HUNTER J M et al, 341
FRIEDEL j.See TARDIEU J C, 138 HAFIZ S. See GRICE G C, 317
FROM E. See JENSEN J R et al, 30 HANLEY O. See MAW R D, 408
FULFORD K W M, CAITERALL R D, HOINVILLE E, LIM K S, HARRIS J R W. See MUNDAY P E et al, 103, 314
WILSON G D: Social and psychological factors in the HARRISON W O. See ZAJDOWICZ T R et al, 176
distribution of STD in male clinic attenders. HARTLEY C. See WOODMAN C B i et al, 311
I Demographic and social factors, 376 II Personality HARVEY J M, GLEN E, WATSON G S: Buschke-Loewenstein
disorders, psychiatric illness, and abnormal sexual tumour of the penis: a case report, 273
attitudes, 381 III Sexual activity, 386 Hepatitis B, contact tracing in, 314
FULLER A. See WOODMAN C B J et al, 311 Hepatitis B virus infection in homosexual men, 277
FUNG H W and NG W W S: Penicillinase-producing Herpes, genital, efficacy of vaccine Ac NFU, (S-) MRC 5
N gonorrhoeae in 21 patients attending an STD clinic in after initial clinical episode, 311
Hong Kong (correspondence), 138 Herpes, initial, topical acyclovir in treatment of, 116
See QVIGSTAD E et al, 189
FYLLING P. Herpes simplex virus types 1 and 2 in genital herpes in
Strasbourg, France, 138
HERZOG C, ISON C A, EASMON C S F: Antimicrobial sensitivity
GABRIEL Gand THIN R N T: Clotrimazole and econazole in the of Neisseria gonorrhoeae: comparison of penicillinase
treatment of vaginal candidosis: a single blind producing and non-penicillinase producing strains, 289
comparison, 56 HETHERINGTON C M. See STREET D A et al, 249
GABRIEL G and THIN R N T: Treatment of anogenital warts: HIRA S K. See ATTILI V R et al, 269
comparison of trichloracetic acid and podophyllin versus HOINVILLE E. See FULFORD K W M et al, 376, 381, 386
podophyllin alone, 124 HOLMES D. See ATIA W A et al, 293
GABRIEL G. See SCHOBER P C et al, 217 Homosexual, lymphogranuloma venereum of the rectum
Gardnerella associated nonspecific vaginitis, amine content in, 196
of vaginal fluid from patients with, 302 Homosexuals, Entamoeba histolytica in, 193
Oardnerella vaginalis and anaerobic bacteria in genital Homosexuals, hepatitis B virus infections in, 277
disease, 111 Homosexuals, immunocompromise syndrome, prevalence
GIBSON J A. See DAROUGAR S et al, 53 of possible risk factors and screening for the prodrome
GILMOUR H M. See McMILLAN A et al, 260 using an accurate white cell count, 127
GLEN E. See HARVEY J M et al, 273 Homosexuals, proctitis in, a diagnostic problem, 260
Index 415
Hong Kong, penicillinase-producing N gonorrhoeae in 21 Lymphogranuloma venereum of the rectum in a
STD clinic patients, 138 homosexual man, 196
HORNER T. See MAW R D et al, 407 LYNCH D. See GOLDMEIER D et al, 127
HUNTER J M, FORSEY T, DAROUGAR S, SMITH I W, PEUTHERER J F,
MacAULAY A: Serotypes of antibodies against chlamydiae MacAULAY A. See HUNTER J M et al, 341
(correspondence), 341 MaCLENNAN I. See SARGEAUNT P G et al, 193
HUNTER J M. See YOUNG H et al, 340 McDONALD W. See MUNDAY P E et al, 314
Hurst, Dr E Weston, a reappraisal of non-specific genital McGOLDRICK I A. See SCRIMGEOUR E M et al, 198
infection with reference to his work, 394 MacLEAN I W. See FAST M v et al, 320
McMILLAN A, GILMOUR H M, SLATFORD K, McNEILLAGE G J C:
IDAJADI A. See SASTROWIDJOJO H, 98 Proctitis in homosexual men: a diagnostic problem, 260
India, penicillinase producing N gonorrhoeae in, 278 McNEILLAGE G J C. See McMILLAN A et al, 260
Iran, chlamydial genital infection in prostitutes in, 53 MASFARI A N, KINGHORN G R, DUERDEN B i: Anaerobes in
ISERIEF C 0 A See ORANJE A P et al, 85 genitourinary infections in men, 255
ISON C A. See HERZOG C et al, 289 MATUHASI T. See KOBAYASHI S et al, 1
MAW R D, HANLEY 0: Cervical cytology figures for 1970-81
Japan, penicillinase-producing N gonorrhoeae in, 37 (correspondence), 408
JAREMA A J. See ROMANOWSKI B et al, 225 MAW R D, HORNER T, BARR J: Comparison of procaine
JENSEN J R, THESTRUP-PEDERSEN K, FROM E: Fluctuations in penicillin, mezlocillin, and doxycycline in treatment of
natural killer cell activity in early syphilis, 30 uncomplicated gonorrhoea (correspondence), 407
JERVE F. See QVIGSTAD E et al, 189 MEADEN J D. See LACEY C J N et al, 277
JEYASINGH P. See MURUGAN S et al, 402 MELLARS J B. See GOLDMEIER D et al, 127
JOHNSON A P, OSBORN M F, ROWNTREE S, THOMAS B J, MELLING J. See WOODMAN C B J et al, 311
TAYLOR-ROBINSON D: A study of inactivation of Mezlocillin compared with procaine penicillin and
Chlamydia trachomatis by normal human serum, 369 doxycycline in gonorrhoea, 407
JOHNSON S. See ODUGBEMI T O et al, 41 MICHEL M F. See ORANJE A P et al, 85, 89
JOHNSTON N A: See JONES R R et al, 33 MINDEL A: Lymphogranuloma venereum of the rectum in a
JONES B M. See KINGHORN G R 278. homosexual man: a case report, 196
JONES B R. See DAROUGAR S et al, 53 Minocycline compared with tetracycline in non-gonococcal
JONES R R, PUSEY C, SCHIFFERLI J, JOHNSTON N A: Essential urethritis, 245
mixed cryoglobulinaemia with false-positive serological MIRZA N B. NSANZE H, D'COSTA L J, PIOT P: Microbiology of
tests for syphilis, 33 vaginal discharge in Nairboi, Kenya, 186
MIZUGUCHI Y. See URABE S et al, 37
KAUR P. See SINGH K G et al, 278 M0LLER B R: Postgonococcal conjunctivitis caused by
Kenya, microbiology of vaginal discharge in Nairobi, 186 Chtamydia trachomatis case report, 109
KERBS S B J. See ZAJDOWICZ T R et al, 176 MONDELLO F. See FANTASIA M et al, 342
KINANE D F, BLACKWELL C C, WINSTANLEY F P, WEIR D M: Blood Monkeys, squirrel, infection with T vaginalis as model for
group, secretor status, and susceptibility to infection by infection in women, 249
Neisseria gonorrhoeae, 44 MORGAN-CAPNER P. See GOH B T et al, 373
KINGHORN G. R. and JONES B M: Non-specific vaginitis MORI K. See SORVILLO F et al, 342
(correspondence) 278 MORRIS C A: Continuing value of the VDRL test and
KINGHORN G R. See MASFARI A N et al, 255 biological false reactions (correspondence), 340
KINGHORN G R. See TALBOT M D et al, 277 MORRISON-PLUMMER J, ALDERETE J F, BASEMAN J B: Enzyme-
KOBAYASHI S, YAMAYA S-I, SUGAHARA T, MUTUHASI T: linked immunosorbent assay for the detection of serum
Microcapsule agglutination test for T pallidum antibody to outer membrane proteins of Treponema
antibodies: a new serodiagnostic test for syphilis, 1 pallidum, 75
MORTON R S: A reappraisal of non-specific genital infection
LACEY C J N, MEADEN J D, CLARKE S K R: Hepatitis B virus with reference to the work of the late Dr E Weston
infections in homosexual men (correspondence), 277 Hurst, 394
LAUFS R. See LINDENSCHMIDT E-G et al, 151 MOSKOPHIDIS M. See MO.LLER F, 80
LEDGER W J. See TOTH A et al, 105 MOSS S: Isolation and identification of anaerobic organisms
LIM K S. See FULFORD K W M et al, 376, 381, 386 from the male and female urogenital tracts, 182
LIM K S. See GOH B T et al, 373 MSSVD: secretary's report to the 61st annual general
LINDENSCHMIDT E-G, LAUFS R, MULLER F: Microenzyme- meeting, 1982, 68
linked immunosorbent assay for the detection of specific MULLER F and MOSKOPHIDIS M: Estimation of the local
IgM antibodies in human syphilis, 151 production of antibodies to Treponema pallidum in the
LING J. See NG w s et al, 232 central nervous system of patients with neurosyphilis, 80
London, imported penicillinase producing N gonorrhoeae MUNDAY P E, McDONALD W, MURRAY-SYKES K M, HARRIS J R W:
becomes endemic in, 364 Contact tracing in hepatitis B infection, 314
LOO P S, FELMINGHAM D, RIDGWAY G L, ORIEL J D: Treatment MUNDAY P E, PRITCHARD G, HARRIS J R W, TAYLOR-ROBINSON D:
of gonococcal infections in men with single dose Prevalence of chlamydial infection in promiscuous
thiamphenicol (correspondence), 407 women, 103
416 British Journal of Venereal Diseases
MURRAY-SYKES K M. See MUNDAY P E et al, 314 OGUNBANJO B O. See ASHIRUJ o et al, 325
MURUGAN S, JEYASINGH P, PRASAD P V S: Chancriform papule: ORANJE A P, ISERIEF C 0 A, De ROO A, STOLZ E, MICHEL M F:
a case report, 402 Antibodies to gonococcal pili in women with
asymptomatic gonorrhoea: diagnostic value of the
NABARRO J M. See THIN R N T et al, 116 ELISA for testing women attending an STD clinic,
NAKEEB S. See PIERCE C S et al, 157 85
NAKEEB S M. See WICHER K et al, 349 ORANJE A P, REIMANN K, De ROO A, SCHOUTEN H J A, STOLZ E,
Neisseria gonorrhoeae, antimicrobial sensitivity of MICHEL M F: Enzyme-linked immunosorbent assay for
penicillinase and non-penicillinase producing strains, 289 detecting gonococcal antibodies using two antigenically
Ngonorrhoeae, chemotactic activity of, 92 different gonococcal pili as antigen, 89
N.gonorrhoeae from Africa, plasmid profile, serogrouping ORANJE A P, REIMANN K, VAN EIJK R V W, SCHOUTEN H J A, De
and auxotyping, 41 ROO A, TIDEMAN G J, STOLZ E, MICHEL M F: Gonococcal
N gonorrhoeae infection and blood group and secretor serology: a comparison of three different tests, 47
status, 44 ORIEL J D and RIDGWAY G L: Comparison of tetracycline
N gonorrhoeae isolates from the Far East, epidemiological and minocycline in the treatment of non-gonococcal
characterisation, 285 urethritis, 245
N gonorrhoeae, penicillinase-producing, cefuroxime, ORIEL J D. See LOO P s et al, 407
thiamphenicol, spectinomycin, and penicillin G in ORIEL J D. See SARGEAUNT P G et al, 193
uncomplicated infections due to, 172 ORIEL J D. See WALKER P G et al, 120, 327
N gonorrhoeae, penicillinase producing, imported, OSBORN M F. See JOHNSON A P et al, 369
becomes endemic in London, 364 OSOBA A D. See ASHIRU J o et al, 325
N gonorrhoeae, penicillinase producing, in India, 278
N gonorrhoeae, penicillinase-producing in Japan, 37 PALMBLAD J. See SANDSTROM E et al, 92
N gonorrhoeae, penicillinase-producing, in prostitutes in PANDEY S S. See SINGH K G et al, 278
Surabaya, 98 PANIKABUTRA K, ARIYARIT C, CHITWARAKORN A, SAENSANOH C:
N gonorrhoeae, penicillinase producing, in Rome 342 Cefaclor and cefamandole as alternatives to spectino-
N gonorrhoeae, penicillinase-producing in 21 STD clinic mycin in the treatment of men with uncomplicated
patients, 138 gonorrhoea, 298
N gonorrhoeae, penicillinase-producing, isolates from PANJA S K: Urethral syndrome in women attending a clinic
different localities in S E Asia, susceptibility to 15 for sexually transmitted diseases, 179
antibiotics, 232 PATTMAN R s and SCHOFIELD C B S: Problem orientated
N gonorrhoeae, penicillinase-producing, single 1 g dose of categorisation of "other conditions" seen in a
cefotaxime for treatment of, 100 genitourinary medicine clinic, 63
N gonorrhoeae penicillinase producing, vancomycin Pelvic inflammatory disease associated with C trachomatis
sensitive, 277 after therapeutic abortion, 189
N gonorrhoeae, stability of typing markers after natural Penicillin G in uncomplicated infections due to
transmission, 237 penicillinase-producing strains of N gonorrhoeae, 172
Neisserial colonisation of the pharynx, 228 Penis, Buschke-Loewenstein tumour of, 273
Neurosyphilis, estimation of locally produced antibodies to PERKINS G. See ODUGBEMI T o et al, 41, 285
Tpallidum in the CNS, 80 PEUTHERER J F. See HUNTER J M et al, 341
Neurosyphilis, treatment with chloramphenicol, 225 Pharynx, neisserial colonisation of, 228
NEWQUIST R L. See ZAJDOWICZ T R et al, 176 PHILPOT C R. See BRADFORD D L, 330
NG W S, CHAU P Y, LING J, ECHEVERRIA P, ROCKHILL R, PHILLIPS I. See THIN R N et al, 364
ARNOLD K: Penicillinase-producing Neisseria gonorrhoeae PIERCE C S, WICHER K, NAKEEB S: Experimental syphilis:
isolates from different localities in south east Asia: guinea pig model, 157
susceptibility to 15 antibiotics, 232 PIOT P. See MIRZA N B et al, 186
NG W W S. See FUNG H W, 138 PIZIAK M. See ODUGBEMI T o et al, 285
Nigeria, northern, STD in, 202 PLUMMER F A. See FAST M v et al, 320
Non-specific genital infection, a reappraisal with reference Podophyllin alone compared with podophyllin and
to the work of Dr E Weston Hurst, 394 trichloracetic acid in the treatment of anogenital warts,
Non-specific vaginitis, 278 124
NSANZE H. See FAST M v et al, 320 Postgonococcal conjunctivitis caused by C trachomatis, 109
NSANZE H. See MIRZA N B et al, 186 PRASAD P V S. See MURUGAN S et al, 402
PRITCHARD G. See MUNDAY P E et al, 103
OATES, J K. See SARGEAUNT P G et at, 193 Problem orientated categorisation of "other conditions"
ODUGBEMI T 0, BROWN S T, BIDDLE J, JOHNSON S, PERKINS G, De seen in a genitourinary medicine clinic, 63
WITT W, ALBRITTON W L: Plasmid profile, serogrouping, Procaine penicillin compared with mezlocillin and
and auxotyping of Neisseria gonorrhoeae isolates doxycycline in gonorrhoea, 407
from Africa, 41 Procaine penicillin v cefoxitin in treatment of
ODUGBEMI T 0, WHITTINGTON W L, DeWITT W, PERKINS G, gonorrhoea, 406
JOHNSON S, BIDDLE J, PIZIAK M, ALBRITTON W L: Proctitis in homosexuals, a diagnostic problem, 260
Epidemiological characterisation of Neisseria gonor- Prostatic fluid, isolation of C trachomatis in association
rhoeae isolates from the Far East, 285 with inflammatory joint or eye disease, 373
Index 417
Prostatitis, non-bacterial, a method for recognising, 306 STD-third African regional conference, 337
Prostitutes in Surabaya, penicillinase-producing N SHAHIDULLAH M. See WALSH R J et al, 242
gonorrhoeae among, 98 SIMMONS P D and THIN R N T: A method for recognising non-
Prostitutes, Iranian, chlamydial genital infection in, 53 bacterial prostatitis: preliminary observations, 306
PUSEY C. See JONES R R et al, 33 SINGER A. See WALKER P G et al, 327
SINGH G. See SINGH K G et al, 278
QUIST E E, REPESH L A, ZELEZNIKAR R, and FITZGERALD T J: SINGH K G, SINGH G, PANDEY S S, KAUR P: Penicillinase
Interaction of T pallidum with isolated rabbit capillary producing Neisseria gonorrhoeae in India (corres-
tissue, 11 pondence), 278
QVIGSTAD E, SKAUG K, JERVE F, FYLLING P, and ULSTRUP J C: SKAUG K. See QVIGSTAD E et al, 189
Pelvic inflammatory disease associated with Chiamydia SKINNER G R B. See WOODMAN C B J et al, 311
trachomatis infection after therapeutic abortion; a SLACK R C B. See WALSH R J et al, 242
prospective study, 189 SLATFORD K. See McMILLAN A et al, 260
SMITH I W. See HUNTER J M et al, 341
SMITH S J. See ARKO R J et al, 94
REIMANN K. See ORANJE A P et al, 47
SORVILLO F, MORI K, SEWAKE W, FISHMAN L: Sexual
REPESH L A. See QUIST E E et al, 11
RIDGWAY G L. See LOO P S et al, 407
transmission of Strongyloides stercoralis among
RIDGWAY G L. See ORIEL J D, 245
homosexual men (correspondence), 324
ROBERTSON D H H. See YOUNG H et al, 340
Spectinomycin in uncomplicated infections due to
ROCKHILL R. See NG w S et al, 232
penicillinase-producing strains of N gonorrhoeae, 172
ROMANOWSKI B, STARREVELD E, and JAREMA A J: Treatment SPENCER R C. See TALBOT M D et al, 277
of neurosyphilis with chloramphenicol: a case report, 225 STARREVELD E. See ROMANOWSKI B et al, 225
Rome, P-lactamase producing N gonorrhoeae in, 342 STARZYCKI Z: Primary syphilis of the fingers, 169
RONALD A R. See FAST M v et al, 320
STEINER B. See WONG G H w et al, 21, 220
ROTOWA N A. See ASHIRU J o et al, 325
STOCKER D. See WOODMAN C B J et al, 311
ROWNTREE S. See JOHNSON A P et al, 369
STOLZ E. See ORANJE A P et al, 47, 85, 89
Strasbourg, herpes simplex virus types I and 2 in genital
herpes in, 138
SAENSANOH C. See PANIKABUTRA K et al, 298 STREET D A, TAYLOR-ROBINSON D, HETHERINGTON C M:
SANCHES P L. See ZAJDOWICZ T R et al, 176 Infection of female squirrel monkeys (Saimiri sciureus)
SANDERSON B E, WHITE E, BALSDON M J: Amine content of with Trichomonas vaginalis as a model of trichomoniasis
vaginal fluid from patients with trichomoniasis and in women, 249
gardnerella associated non-specific vaginitis, 302 SUGAHARA T. See KOBAYASHI S et al, 1
SANDSTROM E, VENIZELOS N, PALMBLAD J: Chemotactic SUGRUE D. See WOODMAN C B J et al, 311
activity of N gonorrhoeae, 92 Sulphamethoxazole compared with co-trimoxazole in
SARGEAUNT P G, OATES J K, MaCLENNAN 1, ORIEL J D, treatment of chancroid, 320
GOLDMEIER D: Entamoeba histolytica in male homo- Sultamicillin in treatment of gonorrhoea, 293
sexuals, 193 SUMATHIPALA A H T. See VEERAVAHAU M et al, 406
SASTROWIDJOJO H and IDAJADI A: Penicillinase-producing Surabaya, penicillinase-producing N gonorrhoeae among
Neisseria gonorrhoeae among prostitutes in Surabaya, 98 prostitutes in, 98
SCHIFFERLI J. See JONES R R et al, 33 Syphilis, chemotherapy and cure of, by arsenic: Paul
Schistosomal genital granulomas - 10 cases, 269 Ehrlich, 404
SCHOBER P C, GABRIEL G, WHITE P, FELTON W F, THIN R N: How Syphilis, early, fluctuations in natural killer cell activity in,
infectious is syphilis?, 217 30
SCHOFIELD C B S. See PATTMAN R S, 63 Syphilis, experimental: guinea pig model, 157
SCHOUTEN H J A. See ORANJE A P et al, 47, 89 Syphilis, how infectious?, 217
SCOTT R. See WALSH R J et al, 242 Syphilis, primary of the fingers, 169
SCRIMGEOUR E M, SENGUPTA S K, McGOLDRICK I A: Primary Syphilis, secondary, uveitis due to, 397
endometrial and endocervical granuloma inguinale Syphilis serology, continuing value of VDRL test and
(donovanosis): a case report, 198 biological false reactions, 340
SENGUPTA S K. See SCRIMGEOUR E M et al, 198 Syphilis serology, differences in THA, TPHA, and VDRL
SENTERFIT L B. See TOTHA A et al, 105 test titres, 145
SEQUEIRA P J L: Serological diagnosis of untreated early Syphilis serology, false-positive with essential mixed
syphilis: importance of the differences in THA, TPHA, cryoglobulinaemia, 33
and VDRL test titres, 145 Syphilis serology, microcapsule agglutination test for
SEWAKE W. See SORVILLO F et al, 342 Tpallidum antibodies, 1
Sexually transmitted disease centres, survey of, in Syphilis serology: microenzyme-linked immunosorbent
Australia, 330 assay for specific IgM antibodies, 151
STD in male clinic attenders, social and psychological Syphilis serology, role of the VDRL test, 8, 340, 341
factors in distribution of, 376, 381, 386
STD in northern Nigeria, 202
STD in the Republic of Ireland, 66 TABAQCHALI S, WILKS M, THIN R N T: Gardnerella vaginalis
STD-seventh Indian national conference, 335 and anaerobic bacteria in genital disease, 111
418 British Journal of Venereal Diseases
TAIT I A: Uveitis due to secondary syphilis, 397 TUPASI T E, CRISOLOGO L B, TORRES C A, CALUBIRAN 0 V, DE
TALBOT M D, SPENCER R C, KINGHORN G R: Vancomycin JESUS I: Cefuroxime, thiamphenicol, spectinomycin and
sensitive penicillinase producing Neisseria gonorrhoeae penicillin G in uncomplicated infections due to
(correspondence), 277 penicillinase-producing strains of Neisseria gonorrhoeae,
Tampons, vaginal, antigonococcal effects of, 94 172
TARDIKEU J c and FRIEDEL J: Incidence of herpes simplex
virus types I and 2 in herpes genitalis in Strasbourg, ULSTRUP J C. See QVIGSTAD E et al, 189
France (correspondence), 138 URABE S, YOSHIDA S-I, and MIZUGUCHI Y: Epidemiology and
TAYLOR-ROBINSON D. See JOHNSON A P et al, 369 treatment of gonorrhoea caused by penicillinase-
TAYLOR-ROBINSON D. See MUNDAY P E et al, 103 producing strains of Neisseria gonorrhoeae in Fukuoka,
TAYLOR-ROBINSON D. See STREET D A et al, 249 Japan, 37
TEJERINA A. See WALKER P G et al, 120 Urethral syndrome in women attending an STD clinic, 179
Tetracycline compared with minocycline in non-gonococcal Uveitis due to secondary syphilis, 397
urethritis, 245
THESTRUP-PEDERSEN K. See JENSEN J R et al, 30 Vancomycin sensitive penicillinase producing N
Thiamphenicol in uncomplicated infections due to gonorrhoeae, 277
penicillinase-producing strains of N gonorrhoeae, 172 VAN DEN HOEK J A R. See DE KONING et al, 100
Thiamphenicol, single dose in treatment of VAN EIJK R V W. See ORANJE A P et al, 47
gonorrhoea, 407 VAN KLINGEREN B. See DE KONING et al, 100
THIN R N, BARLOW D, EYKYN S, PHILLIPS I: Imported VEERAVAHAU M, SUMATHIPALA A H T, CLAY J D: Cefoxitin v
penicillinase producing Neisseria gonorrhoeae becomes procaine penicillin in the treatment of uncomplicated
endemic in London, 364 gonorrhoea (correspondence), 406
THIN R N, NABARRO J M, DAVIDSON PARKER J, FIDDIAN A P: Venereal Disease Research Laboratory test, role in
Topical acyclovir in the treatment of initial herpes, 116 detection of syphilis, 8
THIN R N T. See BHARGAVA R K, 131 VENIZELOS N. See SANDSTROM E et al, 92
THIN R N T. See GABRIEL G, 56, 124
THIN R N. See SCHOBER P C et al, 217 WALKER P G, COLLEY N V, GRUBB C, TEJERINA A, ORIEL J D:
THIN R N. See SIMMONS P D, 306 Abnormalities of the uterine cervix in women with vulval
THIN R N. See TABAQCHALI S et al, 111 warts: a preliminary communication, 120
THOMAS B J. See JOHNSON A P et al, 369 WALKER P G, SINGER A, DYSON J L, ORIEL J D: Natural history
THORBURN A L: Paul Ehrlich: pioneer of chemotherapy and of cervical epithelial abnormalities in patients with vulval
cure by arsenic (1854-1915), 404 warts: a colposcopic study, 327
TIDEMAN G J. See ORANJE A P et al, 47 WALSH R J, SCOTT R, BITTINER J B, SHAHIDULLAH M,
TORRES C A. See TUPASI T E et al, 172 SLACK R C B: Acrosoxacin in the treatment of
TOTH A, SENTERFIT L B, LEDGER W J: Secondary uncomplicated gonorrhoea, 242
amenorrhoea associated with Chlamydia trachomatis Warts, anogenital, comparison of podophyllin alone with
infection, 105 podophyllin and trichloracetic acid in the treatment of,
TREHARNE J D. See DAROUGAR S et al, 53 124
Treponema pallidum antibodies, microcapsule Warts, oral, 325
agglutination test for, 1 Warts, vulval, abnormalities of the uterine cervix in women
T pallidum, ELISA for detection of serum antibody to with, 120
outer membrane proteins of, 75 Warts, vulval, colposcopy of cervical epithelial
T pallidum, estimation of locally produced antibodies in abnormalities in patients with, 327
the CNS in patients with neurosyphilis, 80 WATSON G S. See HARVEY J M et al, 273
T pallidum, factors affecting attachment to mammalian WAUGH M A: MSSVD: secretary's report to the 61st annual
cells in vitro, 21 general meeting, 1982, 68
T pallidum, immunopathology of rabbit testes infected WEIR D M. See KINANE D F et al, 44
by, 349 WHITE E. See SANDERSON B E et al, 302
T pallidum, interaction with isolated rabbit capillary WHITE P. See SCHOBER P C et al, 217
tissues, 11 WHITTINGTON W L. See ODUGBEMI T o et al, 285
Tpallidum, synthesis of antibodies in rabbit testes infected WIBLIN C. See WOODMAN C B J et al, 311
by, 359 WICHER K, WICHER V, NAKEEB S M, DUBISKI S: Studies
of rabbit
Treponemes, motility, attachment to mammalian cells and testes infected with Treponema pallidum. I
infection in rabbits, effect of syphilitic rabbit sera on, Immunopathology, 349
220 WICHER K. See PIERCE C s et al, 157
Trichloracetic acid and podophyllin, compared with WICHER V. See WICHER K et al, 349
podophyllin alone in the treatment of anogenital warts, WICHER v and WICHER K: Studies of rabbit testes infected
124 with Treponema pallidum. II Local synthesis of
Trichomonas vaginalis, amine content of vaginal fluid from antibodies, 359
patients with, 302 WICHER K. See WICHER v, 359
T vaginalis infection in female squirrel monkeys as model WILKINS G. See WOODMAN C B J et al, 311
for infection in women, 249 WILKS M. See TABAQCHALI S et al, 111
Index 419
WILSON G D.See FULFORD K W M et al, 376, 381, 386 YAMAYA S-I. See KOBAYASHI S et al, 1
WINSTANLEY F P: See KINANE D F et at, 44 YOSHIDA S-I. See URABE S et al, 37
WOODMAN C B J, BUCHAN A, FULLER A, HARTLEY C, SKINNER G R B, YOUNG H and BAIN S S R: Neisserial colonisation of the
STOCKER D, SUGRUE D, CLAY J C, WILKINS G, WIBLIN C, pharynx, 228
MELLING J: Efficacy of vaccine Ac NFU1 (S-) MRC 5 YOUNG H, ROBERTSON D H H, HUNTER J M: Role of the VDRL
given after an initial clinical episode in the prevention of test in detection of syphilis (correspondence), 340
herpes genitalis, 311
WONG G H W, STEINER B, GRAVES S: Effect of syphilitic rabbit ZAJDOWICZ T R, SANCHES P L, BERG S W, KERBS S B J, NEWQUIST
sera taken at different periods after infection on R L, HARRISON W 0: Comparison of ceftriaxone with
treponemal motility, attachment to mammalian cells in cefoxitin in the treatment of penicillin-resistant
vitro, and infection in rabbits, 220 gonococcal urethritis, 176
WONG G H W, STEINER B, FAINE S, GRAVES S: Factors affecting ZELEZNIKAR R. See QUIST E E et at, 11
the attachment of T pallidum to mammalian cells in
vitro, 21
WONG K-H. See ARKO R i et al, 94
Br J Vener Dis 1983; 59:420-5
Index to subjects of articles abstracted, 1983
*Indicates that only the title is given.
Acquired immunodeficiency syndrome, current status, Candidosis: patient compliance and short term treatment
348* regimen, 281*
AIDS, disseminated M avium intracellulare in two men Candidosis, recurrent vaginal, systemic ketoconazole treat-
with, 348 ment, 73*
AIDS in four homosexual men, 348* Candidosis, recurrent vulvovaginal, 282*
AIDS in male homosexuals, chronic perianal herpes Candidosis: results of 500 mg Canesten single dose pessaries,
simplex, 73 282*
Acyclovir, intravenous, in genital herpes, 143* Candidosis, vaginal, treated with natamycin, 214*
Acyclovir, oral, controlled trial in recurrent genital herpes, Cefmenoxime v penicillin in gonorrhoea, 345*
143* Cefodizime against N gonorrhoeae, 345*
Acyclovir, oral, in treatment of first episodes of genital Cefonicid, comparison with single dose penicillin in
herpes simplex virus infections, 347 gonococcal urethritis, 141*
Acyclovir, oral, in treatment of genital herpes, 142 Cefotaxime for treatment of uncomplicated gonorrhoea,
Acyclovir, oral, treatment in initial and recurrent genital 213*
herpes, 143* Cefotaxime in gonococcal urethritis in Nigeria, 141*
Acyclovir, topical, double-blind trial in genital herpes, 143* Ceftazidime against N gonorrhoeae, 345*
Acyclovir, topical, in treatment of genital herpes, 142* Cefuroxime compared in gonorrhoea in women, 72*
Acyclovir treatment of experimental genital herpes Cervical neoplasia and C trachomatis, 214*
infections, 143* Chancroid, treatment of 13-lactamase positive H ducreyi
Alaskan natives, repeated gonococcal infections in, 143* with amoxycillin and clavulanic acid, 143
Amoxycillin and clavulanic acid in P-lactamase-positive H Chlamydial aetiology of pelvic inflammatory disease, 72*
ducreyi chancroid, 143 Clamydial cervicitis, an ultrastructural study, 73
Arabinosyladenine monophosphate, double blind trial in Chlamydial cervicitis, colposcopic and histological findings
genital herpes, 282* in, 72*
Australia, STD centres in, 348* Chlamydial cervicitis detection by cervical cytology, 346
Aztreonam against N gonorrhoeae, 345* Chlamydial infection and pelvic pain, laparoscopy in, 346*
Chlamydial genital infection in female guinea pigs: effect of
oestradiol on, 214*
Balanitis, plasma cell, of Zoon, treatment by circumcision, Chlamydial infection, ultrastructural studies in guinea pig
74* urogenital tract, 281*
Blood groups ABO, secretor status and infection by M Chlamydial genital infections, epidemiology, 72*
gonorrhoeae, 345* Chlamydial infections, gynaecological, 72*
Chlamydial major outer membrane proteins, structural
analysis of, 281*
Candida albicans and C tropicalis, difference in virulence Chlamydial salpingitis, endometrial infection in, 142*
of clinical isolates in mice, 142* Chlamydial serum IgG anitibodies measured by ELISA in
C albicans, combined activity of ketoconazole and sulfa- acute salpingitis, 72*
methoxazole against, 282* Chlamydial venereal disease, diagnosis and treatment of,
C albicans strains as means of studying sources of infection, 73*
282* Chlamydia spp, monoclonal antibody characterisation,
C albicans vaginitis, diagnosis and treatment, 282* 346*
C tropicalis and C albicans, difference in virulence of Chiamydia trachomatis and cervical neoplasia, 214*
clinical isolates in mice, 142* C trachomatis and clinical general infections: review, 72*
Candidosis, balanitis, clinical presentation and diagnosis C trachomatis, asyimptomatic male infections, 281*
and treatment, 282* C trachomatis, P-lactam antibiotics and cephalosporins
Candidosis, clotrimazole versus econazole in treatment of, against, 346*
281* C trachomatis, comparison of methods of cultivation and
Candidosis: efficacy of various therapeutic concepts in, isolation, 214*
281* C trachomatis, control mechanisms governing infectivity
Candidosis, epidemiology, pathology, and clinical features of, 73*
of, 1981 status, 282* C trachomatis culture in STD clinics, resources needed,
Candidosis, investigations into pathoaetiologyand diagnosis 142*
of vaginal, 282* C trachomatis, detection of type-specific antibody to LGV
Candidosis, one dose therapy in, 282* serotypes of, with microneutralisation test, 214*
420
Index, 1983, Abstracts Subjects 421
C trachomatis, efficacy of antimicrobials against, 72* Erythromycin and tetracycline compared in C trachomatis
C trachomatis, endometritis, perihepatitis, and positive male and female partners, 142*
meningoencephalitis, 73* Escherichia coli, expression of Tpallidum antigens in, 69*
C trachomatis, growth in medium containing calf serum,
281*
C trachomatis IgG antibodies, rapid immunoperoxidase Gardnerella vaginalis, anaerobes and vaginal discharge, 74*
assay for, 346* G vaginalis, characterisation by gas chromatography, 74*
C trachomatis inclusions in McCoy cell cultures with o vaginalis, identification of, 347
fluorescein conjugated monoclonal antibodies, 346* G vaginalis, infection, comparison of culture and
C trachomatis infection of mouse trophoblasts, 214* microscopy for diagnosis, 74
C trachomatis, infections in women with urogenital G vaginalis, minimal criteria for identification of, 348
symptoms, 281* G vaginalis, rapid microbiological method for diagnosis,
C trachomatis infections, microbiological diagnosis of, 72* 143*
C trachomatis, infectivity in tissue culture with newborn Gonococcal antibodies produced by urogenital
calf serum, 73* staphylococci, 71*
C trachomatis isolation, simplified methods using multiwell Gonococcal arthritis, 23 cases of, 70*
plate, 281* Gonococcal bacteraemia, murine, natural immunity to,
C trachomatis, localisation of distinct surface antigens on, roles of complement, leucocytes, and sex, 346*
281* Gonococcal colony opacity phenotypes, rates of in vitro
C trachomatis, microplate culture with PAS staining for, changes of, 141*
346* Gonococcal infection, disseminated, 70*
C trachomatis, neutralisation of infectivity with antibodies Gonococcal infection, disseminated, pharynx only culture-
to the major outer membrane protein, 214* positive site, 70
C trachomatis, positive male and female partners, Gonococcal infection, disseminated, study of serum and
comparison of erythromycin and tetracycline treatments, synovial fluid immune complex levels, 71*
142* Gonococcal infection, dissemination of, associated with
C trachomatis proteins, analysis of human serological delayed stimulation of complement-dependent neutrophil
response to, 281* chemotaxis in vitro, 213*
C trachomnatis, repeatedly infected volunteer, long term Gonococcal infection, laboratory diagnosis by genetic
clinical, microbiological and immunological observations transformation, 71*
in, 214* Gonococcal ophthalmia in the 1980's, incidence, aetiology,
C trachomatis-serological diagnosis, 72* and treatment, 283
C trachomatis serotype LGV2, in vitro activity on HeLa Gonococcal peptidoglycan, strain-related differences in
cells, 281* lysozyme sensitivity and extent of 0-acetylation of, 141*
*C trac-homatis serum antibodies, increased frequency in Gonococcal serology, comparison of ELISA, IHA, and
infertility due to distal tube disease, 142* GCFT, 280*
C trachomatis strain HAR13, ultrastructural effect of Gonococcal strains from homosexuals have outer
pernicillin and cycloheximide on, 281* membranes with reduced permeability to hydrophobic
C trachomatis, toxic effect of human polymorphonuclear molecules, 141*
leucocytes on, 142 Gonococcal urethritis, comparison of single dose cefonicid
Clavulanic acid and amoxycillin in [3-lactamase positive H and penicillin, 141*
ducreyi chancroid, 143 Gonococcal urethritis in Nigeria, cefotaxime in, 141*
Clotrimazole, action kinetics of, 282* Gonococcal urethritis, penicillin and spectinomycin in 141*
Clotrimazole, antibacterial activity of different Gonococci and meningococci, immune and non-immune
formulations of, 282* precipitation of human sera with, 141*
C(lotrimazole, pharmacokinetic fundamentals of vaginal Gonococci, improved medium for transport of specimens,
treatment with, 282* 71*
Clotrimazole, single dose 500 mg pessaries, results in Gonococci in guinea pig subcutaneous chambers, effect of
candidosis, 282* anti-pilus antibodies on survival of, 213*
Clotrimazole v econazole in treatment of candidosis, 281* Gonococcus, resistance to infection with, 71*
Clotrimazole, vaginal levels after different doses and days, Gonorrhoea, acute, single intramuscular injection of
282* mezlocillin, 213* (bis)
Colitis, fulminating, Reiter's syndrome complicated by, Gonorrhoea and vaginal spermicides, 213
214 Gonorrhoea, anogenital, and pharyngeal meningococci,
346*
Denmark, early infectious syphilis in, 283 Gonorrhoea, detection by laparoscopic diagnosis of acute
2-Deoxy-D-glucose, failure in treatment of herpes simplex adnexitis, 140*
virus, 215* Gonorrhoea, diagnosis using genetic transformation test on
Disseminated gonococcal inifections, 280* mailed clinical specimens, 213*
Drug usage, recreational, among STD clinic patients, 215 Gonorrhoea during intrapartum period, 212*
Gonorrhoea, female contacts of, rapid evaluation by
Econazole v clotrimazole in treatment of candidosis, 281* limulus lysate test, 141*
422 British Journal of Venereal Diseases
Gonorrhoea in women, comparison of spectinomycin, Herpes simplex, chronic perianal in homosexuals with
cefuroxime, thiamphenicol and penicillin G treatments, acquired immunodeficiency syndrome in, 73
72* Herpes simplex infection simulating a positive
Gonorrhoea in women, value of Gram stained cervical autoinoculation for H ducreyi, 215*
smear, 141* Herpes simplex virus, comparison of ELISA and quantal
Gonorrhoea, pharyngeal, screening for in urban teenagers, microneutralisation test for serotyping, 214*
213 Herpes simplex virus, effects of genetic resistance in
Gonorrhoea, repeated, detection by modified follow up vaginally infected mice, 282*
method, 212* Herpes simplex virus, failure of 2-deoxy-D-glucose in
Gonorrhoea, repeated, in Sheffield, epidemiology of, 283* treatment of, 215*
Gonorrhoea, rosoxacin in uncomplicated, 141* Herpes simplex virus, genital infection, inapparent in
Gonorrhoea, single stain for smears and non-removal of college women, 282*
cervical secretions before obtaining test specimens, 141* Herpes simplex virus, genital, treatment of first episodes
Gonorrhoea treatment, cefmenoxime v penicillin, 345* with oral acyclovir, 347
Gonorrhoea, uncomplicated, comparison of piperacillin Herpes simplex virus, latency in uterosacral ligaments, 143*
and penicillin, 72* Herpes simplex virus proctitis in homosexual men, 347
Gonorrhoea, uncomplicated, treatment with cefotaxime, Herpes simplex virus type 1 in CSF, recovery of 2 strains in
213* herpetic proctitis and meningitis, 282
Great Britain, evidence of endemic transmission of Herpes simplex virus type 2, effect of phosphonoformate
penicillinase-producing N gonorrhoeae in, 144 on symptomatic genital herpes in guinea pigs, 282*
Herpes simplex virus type 2 infection with unusual
generalised manifestations, 347*
Haemophilus ducreyi, P-lactamase-positive, treatment of Herpes simplex virus type 2, restriction endonuclease
chancroid with amoxycillin and clavulanic acid, 143 analysis of DNA from genital isolates, 282*
H ducreyi, enzymatic profile of, 283* Herpes simplex virus type 2, unusual serological response
H ducreyi, identification in a clinical laboratory, 74 of two patients to an early antigen of, 143*
H ducreyi infections, time for reappraisal, 282 Herpes simplex virus types 1 and 2, comparison of typing
H ducreyi in genital ulcers in white men in Johannesburg, with type specific rabbit antisera and restriction
347* endonuclease analysis of viral DNA, 282*
H ducreyi, isolation and cultivation of, 74* Herpes simplex virus types 1 and 2, primary and recurrent
H ducreyi, isolation and rapid identification of, 215*
concomitant genital infection, 347*
H ducreyi, simulated positive auto-inoculation by herpes Herpes simplex virus typing by ELISA with monoclonal
simplex infection, 215* antibodies, 347*
Hepatitis B in homosexuals, prevalence and factors related Homosexuals, acquired immunodeficiency syndrome in,
to transmission, 144 chronic perianal herpes simplex, 73
Herpes, genital, arabinosyladenine monophosphate, Homosexuals, AIDS in four, 348*
double blind placebo controlled study, 282* Homosexuals, characteristics of pathogenic Neisseria
Herpes, genital, detection by tissue culture, fluorescent species isolated from, 280*
antibody technique with biorin-avidin, 282* Homosexuals, gonococcal strains from, have outer
Herpes, genital, diagnosis and treatment of, 143* membranes with reduced permeability to hydrophobic
Herpes, genital, double-blind trial of topical acyclovir, molecules, 141*
143* Homosexuals, hepatitis B in, prevalence and factors related
Herpes, genital, experimental, acyclovir treatment of, 143* to transmission, 144
Herpes, genital, ineffectiveness of topical idoxyuridine in Homosexuals, herpes simplex virus proctitis in, 347
dimethyl sulphoxide, 143*
Herpes, genital, in Israel 1973-80, 215* Idoxyuridine, topical, in dimethyl sulphoxide,
Herpes, genital, initial and recurrent, oral acyclovir in, ineffectiveness in genital herpes, 143*
143* Infertility due to distal tube disease, increased frequency of
Herpes, genital, intravenous acyclovir in, 143* C trachomatis serum antibodies, 142*
Herpes, genital, in women, clinical and urological studies, Israel, genital herpes in, 1973-80, 215*
214*
Herpes, genital, oral acyclovir in treatment of, 142 Jarisch-Herxheimer reaction, role of immune complexes
Herpes, genital, recurrent, oral acylovir controlled trial, in, and early syphilis, 140*
143* Jarish-Herxheimer reaction, studies on pathogenesis, 279
Herpes, genital, recurrent, patient-initiated therapy for, Johannesburg, H ducreyi in genital ulcers in white men in,
143* 347*
Herpes, genital, topical acyclovir in treatment of, 142*
Herpes, genital, virus specific antibodies in sera from
patients with, 143* Ketoconazole and sulfamethoxazole against C albicans,
Herpes gestationis and polymorphic eruptions of 282*
pregnancy, immunoelectron microscopy study of Ketoconazole, systemic, for recurrent vaginal candidosis,
relationship, 347* 73*
Index, 1983, Abstracts Subjects 423
Leucoderma in secondary syphilis, 140* N gonorrhoeae, induction of leukochemotaxis, primary
Leucoderma of penis, reversal in man with secondary skin inflammation and local Schwartzman reaction, 71*
syphilis, 140* N gonorrhoeae infection and ABO blood groups and
Liver involvement with early syphilis, 69 secretor status, 345*
Lymphogranuloma venereum and acute ulcerative N gonorrhoeae in guinea pig chamber model, role of pili
proctitis, 74* and outer membrane vesicles in immunogenecity of,
345*
Meningococci and gonococci, immune and non-immune Ngonorrhoeae, interaction with human neutrophils, effects
of serum and gonococcal opacity, 71*
precipitation of human sera with, 141* N gonorrhoeae, 1251-peptide mapping of protein III from,
Metronidazole, factors affecting activity against T 141 *
vaginalis, 281* N gonorrhoeae, outer membrane proteins of, associated
Metronidazole, sensitivity of T vaginalis to, in medium with with survival in human polymorph phagocytes, 346*
various concentrations of iron and ascorbate, 281* N gonorrhoeae P9, antigenic variation of outer membrane
Mezlocillin in treatment of gonorrhoea, 213* (bis) protein II in colonial variants, 71*
Mycobacterium avium intracellulare, disseminated, in two N gonorrhoeae, penicillinase-producing, analysis of recent
men with AIDS, 348 epidemic of, 144*
Mycoplasma genitalium, a new species from the genital N gonorrhoeae, penicillinase-producing, causing
tract, 346* ophthalmia neonatorum, 70
Mycoplasmas, genital, in healthy volunteers and patients N gonorrhoeae, penicillinase-producing, emergence of
with non-gonococcal urethritis, 214 resistance after spectinomycin treatment, 71*
N gonorrhoeae, penicillinase-producing, epidemiology by
Natamycin, treatment for vaginal candidosis, 214* auxotyping and serogrouping, 71*
Neisseria catarrhalis, isolation of, from men with urethritis, N gonorrhoeae, penicillinase-producing in Great Britain
281* 1977-81, evidence of endemic transmission, 144
N gonorrhoeae, activity of Sch 29, 482, a new oral penem, N gonorrhoeae, penicillinase producing in Netherlands
against, 345* 1981, 280*
N gonorrhoeae, anaerobic survival of clinical isolates and N gonorrhoeae, penicillin resistant, activity of 8 new
laboratory strains, use in transfer and storage, 72* P-lactam antibiotics against, 345*
N gonorrhoeae and urinary tract pathogens, activity of N gonorrhoeae, peptidoglycan biosynthesis in, strains
norfloxacin against, 280* sensitive and resistant to P-lactam antibiotics, 280*
N gonorrhoeae, antibiotic sensitivites in Far East; N gonorrhoeae peptidoglycan, synthesis and modification
comparison of plasmid species from six countries, 141* of, 345*
N gonorrhoeae antibodies, radioimmunoassay for N gonorrhoeae phagocyte recognition of 280*
detection of, 71* N gonorrhoeae phagocytosis and killing by T vaginalis,
N gonorrhoeae, antigenicity of outer membrane proteins 345*
III detected by immunoprecipitation and Western Blot N gonorrhoeae, phenotypic changes in colonial
transfer with monoclonal antibody, 213* morphology, 213*
N gonorrhoeae, antimicrobial susceptibility of, 71* N gonorrhoeae pili antigens, demonstration of antigenic
N gonorrhoeae, characterisation of immune response in heterogenicity using human sera, 71*
subcutaneous chambers of guinea pigs immunised by N gonorrhoeae pili-safety and immunogenicity in humans
ribosomal preparation from, 141* and antibody functions in vitro, 71*
N gonorrhoeae, comparative activity of cefodizime, N gonorrhoeae, pilus expression involves chromosomal
ceftazidime, and aztreonam against, 345* rearrangment, 141*
Ngonorrhoeae, comparison of commercially available New N gonorrhoeae polysaccharide cell wall antigen, detection
York City medium and Martin-Lewis medium for in rabbit model by counter immunoelectrophoresis, 141*
recovery of, 213* N gonorrhoeae, primary cutaneous infections, 70*
N gonorrhoeae, correlation of penicillin sensitivity and N gonorrhoeae, purification and partial characterisation of
complement-dependent bactericidal activity to human major outer membrane protein of, 71*
serum, 72* N gonorrhoeae, purification of pili and outer membrane
N gonorrhoeae, culture medium for confirmation of vesicles of, by wheat germ agglutinin affinity
penicillin-resistance and penicillinase-producing, 72* chromography, 141*
N gonorrhoeae, detection with solid phase enzyme N gonorrhoeae, pyocin-resistant mutants, alterations in
immunoassay, 280* sensitivity to normal human serum and polymixin B, 71*
N gonorrhoeae DNA, correlation of methyl adenine with Ngonorrhoeae, recovery from clinical specimens, effects of
AHU auxotype, 71* different temperatures, transport times, and media, 141*
N gonorrhoeae, effect of anti-pilus antisera on cultured N gonorrhoeae, repeated infections in Alaskan natives,
epithelial cells, 71* 143*
N gonorrhoeae, factors affecting smear and culture tests N gonorrhoeae sensitivity to bactericidal activity of human
for, 141* serum, reliability of plaque assay, 72*
N gonorrhoeae, immunological identification, comparison N gonorrhoeae, serological classification with monoclonal
of commercial reagents, 71* antibodies, 71
424 British Journal of Venereal Diseases
N gonorrhoeae serology: coagglutination serogroups WI Reiter keratitis, 73*
and WII/Ill correspond to different outer membrane Reiter's syndrome, a male and female disease, 73*
protein I molecules, 213* Reiter's syndrome complicated by fulminating colitis, 214
N gonorrhoeae, spread of penicillinase producing and Reiter treponeme antigen, isolation of TR-c, 70*
transfer plasmid from, to N meningitidis, 346* Reiter treponeme flagellum, enzyme-linked immunosorbent
N gonorrhoeae, surface peptide mapping of protein I and assay for IgG antibodies against, 69*
protein III of 4 strains of, 141* Rosaramicin in chlamydia positive and chlamydia negative
N gonorrhoeae, susceptibility to N-formimidoyl- non-gonococcal urethritis, 214*
thienamycin, 213* Rosoxacin in uncomplicated gonorrhoea, 141*
N gonorrhoeae, transformation of, sequence specific DNA
uptake in, 280* Salpingitis, acute, chlamydial serum IgG antibodies in,
N gonorrhoeae, variant pili of autoagglutinating, 71* measured by ELISA, 72*
N meningitidis, pharyngeal and anogenital gonor.hoea, Scabies, an epidemiological reassessment, 347*
346* Scabies, venereal disease in patients in, 74*
N meningitidis, spread of penicillinase producing and Sexually transmitted diseases-audiovisual teaching aids,
transfer plasmids from gonococcus to, 346* 215*
N meningitidis, susceptibility to N-formimidoyl- STD, centres in Australia, 348*
thienamycin, 213* STD clinic patients, recreational drug usage among, 215
Neisseria spp, characteristics of pathogenic, isolated from STD, evaluation of an advertising programme on, 144*
homosexual men, 280* STD in general practice, 144
Netherlands, penicillinase producing gonococci in, in 1981, STD in general practice in Northlands, New Zealand, 74
280* STD, medicare cards for tracing, 348*
Neurosyphilis revisited, 345* STD, multiple, 143*
New Zealand, Northlands, sexually transmitted disease in Sheffield, repeated gonorrhoea in, epidemiology of, 283*
general practice, in, 74 Spectinomycin and penicillin in gonococcal urethritis, 141*
Nigeria, cefotaxime in gonococcal urethritis in, 141* Spectinomycin compared in gonorrhoea in women, 72*
Non-gonococcal urethritis, effect of rosaramicin and Spectinomycin treatment for penicillinase-producing N
tetracycline in chlamydia positive and chlamydia gonorrhoeae, emergence of resistance after, 71*
negative, 214* Spermicides, vaginal, and gonorrhoea, 213
Non-gonococcal urethritis, genital mycoplasmas in, and in Sulfamethoxazole and ketoconazole against C albicans,
healthy volunteers, 214 282*
Non-gonococcal urethritis in males, 73* Syphilis antibodies, isolation of TR-c, a Reiter treponeme
Non-gonococcal urethritis, measurement of antibody to U antigen, 70*
urealyticum in, 281* Syphilis, congenital, as a cause of abnormal
Non-gonococcal urethritis, persistent and recurrent, cardiotocogram, 212
without evidence of current infection, 213* Syphilis, congenital, placental lesions in, 280
Non-gonococcal urethritis, studies on aetiology of, 141* Syphilis, congenital, prevention and diagnosis,
Non-specific vaginitis, diagnostic criteria and microbial and immunological aspects, 279*
epidemiological associations, 283* Syphilis control in populations previously exposed to yaws,
Non-specific vaginitis, motile anaerobic curved rods in, 74*
215* Syphilis, early experimental, serum regulation of in vitro
Norfloxacin against N gonorrhoeae and urinary tract lymphocyte responses in, 140*
pathogens, 280* Syphilis, early infectious, in Denmark, 283
Syphilis, early, role of immune complexes in Jarisch-
Ophthalmia neonatorum caused by penicillinase-producing Herxheimer reaction, 140*
gonococci, 70 Syphilis, early, with liver involvement, 69
Syphilis, experimental, immune complexes in, 280*
Syphilis, humoral immune response to polypeptides of T
Pediculosis pubis coexisting with venereal infection, 143 pallidum, 140*
Pelvic inflammatory disease, aetiology, especially Syphilis, is penicillin always infallible in?, 140*
chlamydial, 72* Syphilitic leukoderma, ultrastructural observations on
Penicillin and spectinomycin in gonococcal urethritis, 141* melanocyte function, 280*
Penicillin compared in uncomplicated gonorrhoea, 72* Syphilis, lymphocyte transformation and the effect of
Penicillin, comparison with single dose cefonicid in circulating immune complexes, 140*
gonococcal urethritis, 141* Syphilis, nodular secondary, 69*
Penicillin concentrations in CSF and serum of syphilis Syphilis, penicillin concentrations in CSF and serum after
patients after intramuscular, intravenous, and oral intramuscular, intravenous and oral administration, 345*
administration, 345* Syphilis, primary, T pallidum in peripheral nerve tissue,
Penicillin G compared in gonorrhoea in women, 72* 212*
Penicillin, is it always infallible in syphilis?, 140* Syphilis, secondary, leucoderma in, 140*
Penicillin v cefmenoxime in gonorrhoea, 345* Syphilis, secondary, reversible, penile leucoderma in, 140*
Piperacillin compared in uncomplicated gonorrhoea, 72* Syphilis serology, AMHA-TP test for screening, 212*
Index, 1983, Abstracts Subjects 425
Syphilis serology, ELISA using sodium desoxycholate- Treponemes, acquired resistance of hamsters to challenge
extracted treponemal antigens, 140* with homologous and heterologous virulent, 140*
Syphilis serology, enzyme-linked immunosorbent assay for Trichomonas vaginalis, alternative pathway of activation to
IgG antibodies against Reiter treponeme flagellum, 69* complement, 142*
Syphilis serology, fluorescent treponemal antibody absorp- T vaginalis antibody in human cervicovaginal secretions,
tion double staining test evaluation, 280* 214*
Syphilis serology, modern, 279* T vaginaiis, antigen specific proliferation responses to
Syphilis serology, purification of Tr-6, a Reiter treponeme peripheral blood lymphocytes, 281*
protein antigen, 212* T vaginalis, canine prostatic secretions kill, 73
Syphilis serology, tests, 212* T vaginalis, factors affecting activity of metronidazole
Syphilis serology: T pallidum haemgglutination assay, against, 281*
miniaturisation, in blood transfusion centre screening, T vaginalis, host plasma proteins on surface of, 142*
279* T vaginalis, identification of membrane proteins of, 347*
Syphilis, transfusion, survival of Tpallidum in donor blood, T vaginalis phagocytosis of N gonorrhoeae, 345*
279* T vaginalis, polymorph chemotaxis to secretions of patho-
Syphilis, treatment of, 212* genic and non-pathogenic, 142*
T vaginalis proteinases, analysis of, 347*
Tetracycline and erythromycin compared in C trachomatis T vaginalis, purine and pyrimidine metabolising activities in
positive male and female partners, 142* extracts of, 281*
Tetracycline in chlamydia positive and chlamydia negative T vaginalis, rapid diagnostic method, 73*
non-gonococcal urethritis, 214* T vaginalis, role of cytoskeleton in natural cell-mediated
Thiamphenicol compared in gonorrhoea in women, 72* cytotoxicity against, 281*
Treponema pallidum and cytomegalovirus specific IgM T vaginalis, sensitivity to metronidazole in medium with
antibodies, rapid detection with passive haemagglutina- various concentrations of iron and ascorbate, 281*
tion, 279* T vaginalis, serum-free modified Trichosel medium for,
T pallidum and human polymorphs, interaction between, 142*
345 Trichosel medium, serum-free modified for T vaginalis,
T pallidum antigen, evaluation of microenzyme-linked 142*
immunosorbent assay with, 69*
Tpallidum antigens, expression in E coli, 69* United States army, venereal disease in, 1775-1900, 144*
Tpallidum Bosnia A strain antigens, ability of macrophages Ureaplasma urealyticum genital infection, subsequent
to process and present, in experimental syphilis, 70* pregnancies among couples treated for, 346
Tpallidum, effect of route of infection with, in vitro cellular U urealyticum in infertile women by laparoscopy, 346*
response to treponemal antigens, 212* U urealyticum, measurement of antibody to, by ELISA and
T pallidum, immune complexes in experimental rabbit detection of antibody responses in patients with non-
infection, 70* gonococcal urethritis, 281*
Tpallidum, immune system responses towards, 280* Urethral infections in men and women, 348*
T pallidum, independent confirmation of in-vitro cultiva- Urethritis in men: benefits, risks, and costs of alternative
tion, 70* strategies of management, 281*
Tpallidum in peripheral nerve tissue of syphilitic chancre, Uterosacral ligaments, latency of herpes simplex virus in,
212* 143*
Tpallidum, molecular protein characterisation, 280*
T pallidum (Nichols), murine monoclonal antibodies
specific for, 70* Venereal diseases in United States army 1775-1900, 144*
Tpallidum outer membrane, solubilisation by detergents to
release axial filaments, 69*
T pallidum polypeptides, humoral immune response in Warts, cervical, isoantigen studies using immuno-
human syphilis to, 140* peroxidase, 348*
T pallidum surface-associated antigens concealed by an Warts, urethral, a new topical treatment, 283*
outer inert layer, 70* Warts, vulval, treatment with laser, 283*
Tpallidum, survival in donor blood, 279*
T pallidum, ultrastructure during phagocytosis and dis-
solution by macrophages, 69* Yaws, late, 279*
Tpertenue in golden hamsters, isolation and transportation Yaws, syphilis control in populations previously exposed
in, 69 to, 74*
Br J VenerDis 1983;59:426-9
Index to authors of articles abstracted, 1983
*Indicates that only the title is given.
Aardoom H A, 280* Blackwell C C, 280* Crithlow C W, 143*
Aasen T, 143* Blackwood L G, 143* CsAng6 P A, 74*
Adams C B, 280* Blake M S, 71* Curran J W, 141*
Adler M W, 143*, 144 Blatchford N R, 73*
Agarwal D S, 71* Blot P, 280 Dalaker K, 72*
Alderete J F, 142*, 347* Blundell J K, 141* Dalton H P, 281* (bis)
Alexander E R, 281* Boackle R J, 142* Damjanou I, 70*
Allen S G, 345* Bohnhoff M, 213*, 280* Danos L M, 346
Allgulander C, 214* Bolan R K, 74* Davidson J C, 279*
Alsuleiman S A, 280* Bos J D, 280* Dawber R P R, 74*
Altman D G, 213* Bowie W R, 72* Dawson C R, 214*
Alvarez-Dardet C, 214 Bowmer M I, 70 Dawson S G, 74
Amsel R, 283* Branolte J H, 282* D'Costa L, 143
Anestad G, 72* Braude A I, 71* de Hoop D, 280*
Aosai F, 281* Braun P, 281* Delauche M C, 70*
Apicella M A, 141* Brooks C, 346 de Miguel C, 214
Arnold A J, 141* Brooks S, 214 Densen P, 213*
Arsenakis M, 143* Brorson J E, 345* Dessenskroon M, 280*
Awer M C, 141* Brown M B, 281*, 346* Diaz J L, 71*
Axelsen N H, 69*, 70*, 212* Brun R, 279* Dick J D, 142*
Azadegan A A, 140 Bryson Y L, 347 Dillon J R, 346*
Buch A, 214* Dillon M, 347
Back A E, 74* Buchanan T M, 71*, 71, 213* Dix R D, 282
Bagasra 0, 70* Burkhart C G, 347* Docherty J J, 282*
Baker-Zander S, 69*, 140* Butler L 0, 71* Doern G V, 281*
Baldigo S M, 73* Donati M, 346*
Ballard R C, 214*, 347* Cahn T, 140* Dorman D A, 346
Balsdon M J, 73* Cajacob A, 279* Dougherty T J, 280*, 345*
Banks J, 214* Caldwell H D, 214*, 281* Downie A G, 345*
Baringer J R, 282 Calhoun J, 143* Duangmam C, 141*
Barlow D, 74* Calubiran 0 V, 72* Dudek E J, 213*
Barrett-Connor E, 143* Casin I M, 283* Duncan W C, 141*, 279
Barron A L, 281* Cassell G H, 281*, 346* Duvic M, 96*
Barrowman J A, 70 Catchpole M U, 70*
Batteiger V B, 281* Cevenini R, 346* Easmon C S F, 71*
Baughn R E, 279, 280* Chabrolle A D, 214* Echeverria P, 141*
Beggs W H, 282* Chacko M R, 213 Edwards T A, 213*
Belli L, 213* Chen K C S, 213* Egere J U, 141*
Bellinger C M, 71* Christensen E S, 214* Eglin R P, 143*
Benedetti J K, 143* Clark R A, 213* Eltonsy M H, 279*
Benes S, 214*, 281* Clark R B, 281* (bis) Engstfeld J, 141*
Benhawi M, 279* Clark V L, 71*, 72* Esser M, 71*
Benijts G, 281* Clarkson T E, 281* Evans B A, 73
Berg S W, 345* Cles L, 346* Everett R M, 347*
Bergstein N A M, 282* Collart P, 140* Everson J S, 71*
Berrie J R H, 144 Coombes G H, 281*, 347*
Bhujwala R A, 73* Cooper M D, 141* Fallon R J, 346*
Biddle J W, 72* Corbeil L B, 346* Farshy C E, 140*, 280*
Bilgeri Y R, 347* Corbeil R R, 346* Fast M, 143
Bird B R, 142* Cordiner J W, 143* Feeley J C, 69*
Bissaillon J G, 71* Corey L, 142*, 143* (quater), 347* Fehniger T E, 140*
Biswas G D, 280* Cramolina G M, 70 Ferenczy A, 283*
Black M M, 347* Crisologo L B, 72* Fiddian A P, 142, 143*
Blackwell A L, 74* Critchlon C, 71* Fife K H, 347*
426
Index, 1983, Abstracts Authors 427
Fischer S H, 71* Harris A B, 346* Kawagoe K, 214*
Fiumara N J, 140*, 143* Harris J R W, 215 Kawana T, 214*
Fleagle G S, 282* Harris J W, 71* Keigher N L, 71*
Fleury F J, 282* Harrison W 0, 345* Keisler D S, 69
Flichman J C, 141* Hart G, 74* Kellogg D S, 72*
Flight R J, 74 Hatcher V A, 282* Kennedy E J, 280*
Folds J D, 140*, 212* Hayashi H, 281* Kerbs S B, 345*
Folds J F, 70* Heckels J E, 71*, 213* Kern E R, 143*, 215*
Ford L C, 282* Heise H, 140* Kerrick G, 143*
Forman L, 142* Heller M, 282 Kettman J R, 70*
Forsum U, 215* Hentzer B, 142* Keyserling H L, 143*
Fortier B, 214* Heyworth P G, 281* Khan M F, 70*
Foy H M, 142* Hickling P, 214 Khan M Y, 72*, 345* (ter)
Francioli P, 345* Hierholzer J C, 347* Kinane K F, 280*
Freundlich L F, 71* Hill E C, 214* King E B, 214*
Friedmankien A E, 215*, 282* Hilton J, 74 Kinge B R, 142
Frithz A, 280* Himmelwright J P, 347* Kinghorn G R, 282, 283*
From E, 140* Hira S K, 141* Kitchener H C, 143*
Hiscock E, 144 Klatzman D, 348*
Gaffoor P M A, 279* Hjelm E, 215* Klebanoff S J, 142
Gallione M A, 281* Hochberg F P, 71* Klein R J, 215*, 282*
Gantz N M, 281* Holbrook T W, 142* Klemp P, 143
Ginsberg M, 143* Holmes K K, 143*, 281* Kliewer K E, 348
Gjonnaess H, 72* Holmes R C, 347* Knap J S, 71*
Glasgow L A, 215* Holterman M, 212* Knight R D J, 71*
Glass R, 214* Hough A J, 214* Kobayasi T, 212*
Gleyzer A, 346* Hsiung G D, 282* Kock L W, 213*
Goh A-J, 141* Hunter E F, 69*, 69, 140*, 280* Koester M, 346*
Goldstein L C, 282* Hunziker N, 279* Kolmorgen K, 140*
Goodell F E, 347 Huraux J M, 214* Kolodkin A B, 71*
Goodhard M E, 141* Hurwitz M D, 70* Komaroff A L, 281*
Goormans E, 282* Huschka U, 279* Koornhof H J, 347*
Gorce M F, 283* Korte W, 282*
Gotschlich E C, 71* Ingham Z Z, 71* Kothe F C, 279*
Graham W R, 69* Iserief C 0 A, 280* Kraminer A, 279*
Granitzka S, 281* Ison C A, 71*, 74 Kraus S J, 141*, 142*, 213*
Graves J F, 280* Ivanoff B, 280 Krause U, 282* (bis)
Greenwood J R, 215* Krauss H, 141*
Grimes E M, 280* Jacob A J, 282* Kreysing W, 281*
Gruninger R P, 345* (bis) Jacobs R P, 73* Krieger J N, 73
Guinan M E, 142* Jacobson M S, 213 Kristensen J K, 142*
Gupta A, 73* Jaffe H W, 213* Kuo C-C, 142
Guymon L F, 71* Jagars G, 74* Kwaasi A A A, 346*
Gyorkey F, 345 Janda W M, 280*
Jawetz E, 214* Labonte R N, 144*
Hadler S C, 144 Jeansson S, 347* Labriola D, 346
Hadley W K, 280* Jick H, 213* Lafond L, 71*
Hafiz S, 282 Johnson A P, 213*, 345* Lagerholm B, 280*
Hagedorn H-J, 279* Jolly J L S, 348 Lambden P R, 71*, 213*
Hagen N, 74* Jonas H S, 280* Landolfo S, 281'
Haguepark M, 345 Jones J, 73* Larsen S A, 280*
Hallen A, 215* Jones J F, 71* Lascolea L J, 73*
Halsos A M, 142, 143* Jones R B, 281* Lassus A, 214*
Hammer C S, 73 Jonsson A, 212* Lawton W D, 213*
Hammerschlag M R, 346* J0rgensen J, 215* Lebberz T B, 282*
Hand C, 144* Judd R C, 141* (bis), 281* LeFrock J L, 140
Handsfield H H, 71*, 213* Jurecka W, 347* Leggat I, 70
Hanff P A, 69*, 140* Juvakoski T, 214* Lerner S A, 213*, 280*
Hanna L, 214* Lesser M L, 346
Hanna N F, 345* Kaaman T, 280* Leventon-Kriss S, 215*
Hannah P, 215* Kaijser B, 345* Levy N J, 281*
Hannan M T, 213 Kampmeier R H, 144* Lichfield J, 69*
Hannani Y, 283* Kataniwa Y, 213* Lind I, 72*
428 British Journal of Venereal Diseases
Ling F W, 212* Miller R L, 281* Pariser H, 144*
Linstead D, 281* Mindel A, 143* Parker B W, 142*
Liska S L, 69, 140* Mizuma K, 213* Parsons N J, 346*
Litt I F, 70 Mkrtichian E, 347 Patel M I, 141*
Loendersloot E W, 282* Mogenson C E, 140* Pattman R S, 140*
Looney D J, 69 Moller B, 142* Patzschke K, 282*
Lopez C, 73 Mondabaugh S M, 71* Pauze M, 346*
Lossick J G, 141* Moore D E, 142* Pedersen N S, 69*, 70*, 212*
Lovett M, 347 Morello J A, 280* Penn C W, 69*, 70*, 71*, 141*, 3454
Lovett M A, 69* Morse S A, 141* Perea E J, 214
Lowhagen G-B, 345* Morton R S, 283* Perera V Y, 141*, 345*, 346*
Lucia H L, 282* Mulenga R C, 141* Perine P L, 69, 72*
Luger A, 212* Muller M, 345* Perkins H R, 141*
Lukehart S A, 140* Munday P E, 213*, 215 Perkins R L, 141*
Lusher M, 346* Munkvad I M, 143 Perry L J, 214*
Lysko P G, 141* Munkvad JM, 74* Petersen C S, 69*, 70*, 212*, 283*
Murray D, 215* Petersen N S, 283
McBride M E, 141* Musher D M, 280*, 345 Peterson E, 282*
McCaughtry M L, 282* Myare G, 71* Peterson K M, 142*
McCormack W M, 214*, 281* Peutherer J F, 282*
McCulley J B, 73* Nachamkin I, 281* Phillips I, 74*, 347
McCutchan J, 144 Nahmias A, 143* Phillips S, 213
McEntegart M G, 282 Nahmias A J, 142* Pierce J M, 283
McFarland L, 141* Natarajan R, 71* Plempel M, 282* (bis)
MacKeen L, 213* National Venereology Council of Plit M, 70*
McManus T J, 215 Australia, 348* Podgore J K, 281*
Madden D L, 282* Naughton H, 346* Poitevin M, 140*
Madgar Y, 283* Nelson S M, 345* (bis) Pope V, 69*
Maeland JA, 71*, 141* Nerurkar L S, 282* Powell H C, 69*
Maitland N J, 282* Neuwelt C M, 73* Pratt G, 279*
Malhotra U L, 71* Newhall W J, 281* Prior R B, 141*
Mallinson H, 346* Newton A J, 70 Pryce D, 283*
Mambo N C, 348* Ng W W S, 141* Puckett A, 279*
Man F, 141* Nielsen A 0, 74*
Manicourt D H, 71* Nilheden E, 347* Quagliarello, V, 348*
Marcus E L, 282* Nilsen A E, 143* Quinn T C, 347
Mardh P-A, 73*, 142*, 346* Nitskansky S G, 140 Qvigstad E, 72*
Maret S M, 70*, 140*, 212* Nobre G N, 74
Marino A F, 144* Norgard M V, 70*
Mark D B, 73* Norris S J, 70* Rajan V J, 141*
Mark W W Jun, 69 Norrod E P, 213* Ralfs I G, 74*
Martin M F R, 214 North M J, 347* Rank R G, 214*, 281*
Martinetto P, 281* Nsanze H, 143 Rannon L, 215*
Martinotti M G, 281* Ratnam A V, 141*
Mason P R, 142* Obaid S R, 345* (bis) Rauchbauch A S, 70*, 140*, 212*
Mauff A C, 347* Oberhofer T R, 74* Raucher H S, 70
May J T, 143* 0degaard K, 71* Reader F, 212
Mayaud C, 348* 0dum L, 72* (bis) Reichman R C, 143*
Mayer L W, 141*, 213* Ogden J, 141* Reimann K, 71*, 280*
Mayo D R, 282* Ohmsmith M J, 280* Rein M F, 73
Mbono 0 0, 141* Okaro J, 141* Remington M, 347*
Meingassner J G, 281* Olbrich M, 282* Rest R F, 71*
Meinhof W, 282* Olsen D, 71* Rhodes J G, 70*
Mendling W, 282* Oranje A P, 71*, 280* Ridge A G, 73*
Menke H E, 279* (bis) Orenstein B, 73* Ripa K T, 72*
Menne T- 215* Oriel J D, 72*, 212* Ritter W, 282*
Merz W G, 142* Orloff S, 71* Roberts R B, 345*
Meyer B, 72* Osborn M F, 345* Robertson D H H, 346*
Meyer T F, 141* O'Shaughnessy M V, 281* Robertson S M, 70*
Michaels E, 348* Oxtoby M J, 141* Robertson W H, 281*
Michel M F, 71*, 281* Rockhill R, 141*
Miller J N, 70*, 140* Paavonen J, 72* R0d T 0, 141*
Miller R D, 141* Pardini S, 214* Rodrigues L G, 142*
Index, 1983, Abstracts Authors 429
Rose D L, 346* Slama T G, 141* Tupasi T E, 72*
Rosedale N, 73* Smeltzer M P, 141*
Rosenthal R S, 141* Smetana Z, 215* Usategui M, 71*
Rosenthal S L, 71* Smith C C, 345*
Rozenbaum W, 348* Smith H, 71*, 141*, 345* Vahcne A, 347*
Rufli T, 279* Smith I W, 282* Vandersluis J J, 279*
Rumpianesi F, 346* Smith R F, 142* Van Eijk R V W, 279*, 280* (bis)
Ryan G M, 212* Sng R-H, 141* Van Embden J D A, 280* (bis)
Ryan T J, 74* So M, 141* Van Klingeren B, 280*
Ryckewaert A, 70* Sohn C C, 348 Van Wijngaarden L J, 280*
Solbert Q, 71* Van Zuuren A, 281*
Saftig V, 282* S0ling J, 140* Vejtorp M, 69*
Saheb S A, 71* Soloff B L, 281* Vesely J, 142*
Saksela E, 72* Solola A S, 212* Vesterinen E, 72*
Salari H, 73* Sonnex T S, 74*
Sands M, 74* Sorbie J, 281* Vignali M, 281*
Vik I S S, 72*
SandstrOm E, 212* Spagna V A, 141*
Sandstrom E G, 71, 71*, 213* Spandoni L R, 142* Virji M, 71*
Sandven P, 71* Sparling P F, 280*
Sanson-Lepors M J, 283* Spiegel C A, 283* Walch R, 142*
Sarov I, 346* Spindle A I, 214* Walfield A M, 69*
Savage W D, 212 Stamm W E, 346*, 348* Wallin J, 215*
Savard E V, 71* Starke W, 69 Wallmark G, 212*
Schachter J, 74*, 214* Starrett L A, 215 Walter P, 280
Schaller K, 282* Stengel H H, 279* Wannemuehler M J, 141*
Schatzki P F, 281* (bis) Stephenson J D, 213* Ward M E, 73*, 283
Scheibel J H, 142* Stergachia A, 213 Watt P J, 213*
Schell R F, 140 Stern R H, 70 Waugh M A, 282*
Schiefer H-G, 141* Stettendorf S, 281*, 282* Weidner W, 141*
Schmidt B L, 212* Stewart J A, 347* Weingarten N M, 279
Schmidt Q, 347* Steyrer K, 212* Weir D M, 280*
Schmidt 0 W, 282* Stickney R, 142* Weisman K, 212*
Schnell J D, 282* Stockli H R, 279* Westbrook W G, 72*
Scholz R, 282* Stolz E, 281* Westrom L, 72*, 142*, 346*
Schreeder M T, 144 Stone J R Jun, 345* White H J, 214*
Schroeter R, 279* Streeter P R, 346* Wider G, 212*
Schroff R W, 348 Su K E, 214* Wiegel U, 279*
Scneweis K E, 282* Sutherland S, 143* Willcox R R, 212*
Scott M J, 70* Sveen K, 71* Williams R P, 213*
Scott M J, 70* Svensson L, 346* Wilson D J, 346
Scott M L, 346* Swanson J, 213* Wingard J R, 142*
Seal D V, 283 Sweet R L, 280* Winstanley F P, 280*
Secher L, 74*, 212* W0lner-Hanssen P, 73*, 142*, 346*
Sell S, 69*, 140* Takizawa K, 214* Wong E S, 348*
Senft H H, 282* Tam M, 346* Woscoff A, 141*
Seth P, 73* Tam M R, 71, 213* Wunderlich A C, 346*
Sever J L, 282* Taylor E, 74*, 347
Shafter W M, 71* Taylor-Robinson D, 281*, 346* Yano A, 281*
Sharma K B, 73* Tenover F C, 71* Yeo K-L, 141*
Shepard M C, 281* Terho P, 72* Yeung K H, 346*
Sherman H, 281* Thelin I, 73* Yoffe R, 215*
Sheth P K, 281* Thompson J S, 143* Yong E C, 142
Shio H, 345* Thompson S E, 144 Yong D C T, 143*
Short H B, 72* Thornley M J, 346* Young F E, 71*, 72*
Siddiqui Y, 72* Thygeson P, 214* Young H, 346*
Sidi A A, 283* Tjiam K H, 281* Young J R, 72*
Siegal F P, 73 Torres C A, 72* Young R J, 279
Siegel M, 71* Toth A, 346 Younger J B, 346*
Silvestri D L, 143* Totten P A, 283* Yui K, 281*
Simpson M L, 72*, 345* (bis) Treharne J D, 72*
Singh R, 71* Trogele M R, 71* Zaidi A A, 141* (bis)
Skaug K, 72* Tully J G, 346* Zweerink H J, 143*
